Clear Search sequence regions


  • adult (1)
  • calcium channel blocker (1)
  • case (3)
  • diagnosis (1)
  • eyelid (1)
  • female (1)
  • humans (1)
  • patient (1)
  • receptor (1)
  • tachycardia (1)
  • tachypnoea (1)
  • tremor (4)
  • vital signs (4)
  • woman (1)
  • Sizes of these terms reflect their relevance to your search.

    Tizanidine, an α2-adrenergic receptor agonist commonly prescribed as a muscle relaxant, has been associated with limited cases of acute intoxication or withdrawal. Here, we present a case of tizanidine withdrawal in a woman in her 40s who presented with an unusual combination of systemic and neurological symptoms. These included hallucinations, decorticate posture, limb and eyelid tremors, along with hypertension, tachycardia and tachypnoea. The diagnosis of tizanidine withdrawal was established by a comprehensive assessment of the patient's medical history and the systematic exclusion of other potential diseases. Our approach to managing the withdrawal symptoms was to initiate symptomatic treatment with a combination of a beta-blocker and a calcium channel blocker. Remarkably, this intervention successfully resolved both vital signs and neurological manifestations by the following day. In conclusion, tizanidine withdrawal is associated with a distinct and diagnostically significant neurological syndrome characterised by hallucinations, decorticate posture, tremors and hypersympathetic vital signs. © BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.

    Citation

    Jun Tanimura, Takao Hashimoto. Case of tizanidine withdrawal showing hallucination, decorticate posture and tremor, with hypersympathetic vital signs. BMJ case reports. 2024 Mar 07;17(3)

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38453230

    View Full Text